FDA Approved: EMSAM — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for EMSAM (selegiline transdermal patch) from Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• EMSAM (selegiline)

Snippet

SUPPL AP for EMSAM (SELEGILINE)